Tag: PRMT5 inhibitor program
Victorian research centre inks major pharma deal
The Australian Cancer Therapeutics Cooperative Research Centre (CTx), their UK based research and commercialisation partner Cancer Research Technology (CRT) and global pharmaceutical giant MSD...
Featured Article
From cost exposure to cost control: Using energy flexibility to protect margins
Electricity price volatility is reshaping the cost base of Australian manufacturing, challenging long-held assumptions that energy can be treated as a stable operational input.
